Meesho

The IPO market, which scaled a record high in 2025 with companies raising an unprecedented Rs 1.76 lakh crore, driven by abundant domestic liquidity, resilient investor confidence and supportive macroeconomic factors, is expected to carry that momentum into the New Year. This exceptional year not only reflected issuers' confidence but also highlighted investors' eagerness to chase listing-day gains and back companies with strong long-term growth potential. A major highlight of the year was the resurgence of startup listings with as many as 18 startups, including Lenskart, Groww, Meesho and PhysicsWallah, going public and collectively raising over Rs 41,000 crore. In 2024, startups raised Rs 29,000 crore from the primary market. This rebound signals a reset in valuation expectations and business models after a period of caution. At the same time, Offer for Sale (OFS) continued to dominate fundraising activity, accounting for about 60 per cent of total capital raised in 2025. Overal

UBS has set a target price of ₹220 per share, while Choice Broking's target stands at ₹200, compared with the current price of around ₹225

The year 2025 has seen over 100 mainboard, and 250+ SME IPOs. From frenzied demand to aggressive pricing among others, here are the key learnings from IPO investing as per experts.

At the high point on Thursday, Meesho stock was up 110 per cent from the IPO price.

The expiry of anchor lock-ins is closely tracked by market participants as it can influence post-IPO stock performance

Meesho stock rose as much as 19 per cent during the day to a new high of ₹214.4 per share, the best session since listing on December 10 this year

Share price of Meesho hit a new high of ₹193.5 on the BSE in Tuesday's intra-day trade, and has zoomed 74 per cent against its issue price of ₹111 per share.

Meesho shares listed at a 45 per cent premium and ended 53 per cent above the issue price, after its IPO was subscribed 79 times and raised Rs 5,421 crore for growth plans

Sensex Today | Stock Market Close Highlights: Tata Steel, Sun Pharma and ITC were top gainers on the 30-share BSE Sensex index. On the flipside, Eternal, Trent and Bharti Airtel were top drags.

Prosus keeps an 11.2% stake after the closely watched listing, adding to a string of Indian tech IPOs

Meesho Share Price Today: Post-listing, Meesho shares continue to trade higher on the bourses on Wednesday

Choice Equity Broking has initiated coverage on Meesho with a 'Buy' rating, citing the company's structural competitive Moats, strong monetisation runway, and accelerating path to profitability

The listing closely mirrored activity in the grey market, where the company's shares were quoted around ₹154 each, indicating a premium of ₹43, or 38.74 per cent over the issue price

Overall subscription for Meesho IPO was strong at 79.03 times, with total bids at 21.96 billion shares against the 277.93 million shares on offer

The Indian consumers' focus on value has pushed Amazon to develop tools such as value dashboards and gamified in-app experiences - innovations now being adopted in other markets

Sources confirmed that SoftBank's investment in value ecommerce player Meesho is sitting at 2x

Meesho IPO allotment: Applicants can verify their status through the NSE and BSE websites or by visiting the IPO registrar, Kfin Technologies

A packed fundraising calendar, an anchor-allocation flashpoint, and a major shift in derivatives trading set the stage for one of the busiest - and most closely watched - weeks in markets

Meesho, Aequs and Vidya Wires drew bids worth nearly Rs 3 trillion, with institutional investors driving subscriptions as high as 120 times the shares on offer

IPO Calendar: Nephrocare, Park Medi World, Wakefit Innovations, and Corona Remedies, are set to open for subscription, aiming to raise a combined ₹3,735 crore